Correction: Anaerobic capacity estimated by the sum of both oxygen equivalents from the glycolytic and phosphagen pathways is dependent on exercise mode: Running versus cycling

An alternate to accumulated oxygen deficit (AOD) for measuring anaerobic contribution: 'AOD_alt' is valid in normoxia and hypoxia

PURPOSE

The gold standard measure of anaerobic contribution is accumulated oxygen deficit (AOD). The purpose of this study was to investigate the validity of an alternate measure, AOD_alt. AOD_alt is the sum of the phosphocreatine and glycolytic contributions, which are estimated from post-exercise oxygen uptake and blood lactate concentration, respectively.

METHODS

In Study One, six women and three men performed 6-min bouts of heavy intensity cycle ergometer exercise, once in normoxia (FIO2 ~ 21%) and twice under hypoxic conditions (FIO2 ~ 15% and ~ 12%). In Study Two, four women and two men performed severe intensity tests to exhaustion, once in normoxia (~ 10 min) and twice in hypoxia (FIO2 ~ 15% and ~ 10%). Physiological responses were measured during exercise and 7 min of recovery.

RESULTS

In 6 min of heavy exercise, Study One, the alternate and criterion measures of anaerobic contribution (AOD_alt and AOD) were correlated, in normoxia and in hypoxia. In exhaustive severe exercise, Study Two, AOD_alt and AOD were correlated (r = 0.77) and similar, in normoxia and at FIO2 ~ 15%. However, AOD_alt and AOD values were neither correlated (r = 0.27) nor similar (57 ± 5 mL·kg-1 vs 51 ± 7 mL·kg-1) at FIO2 ~ 10%.

CONCLUSION

These results confirm the validity of AOD_alt as a measure of anaerobic capacity in severe intensity exercise, demonstrate its validity in heavy exercise, and assert its validity in conditions of hypoxia (FIO2 ~ 12%).

A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time

Compound 1 was previously identified by our team as a glycogen phosphorylase (GP) inhibitor with glucose-lowering activity and demonstrated to have protective effects against myocardial and cerebral ischemia. However, its impact on muscle function has not been clarified. This study is the first to evaluate the long-term effects of GP inhibitors on muscle function and metabolism. After a 28-day administration of Compound 1, we performed assays to assess muscle function and biochemical parameters in rats. We observed reductions in peak holding force, duration, tetanic contraction force, single-contraction force, and electromyographic signals under 20 s and 10 min contraction stimuli. The metabolic analysis showed no significant effects on muscle glycogen, ATP, lactic acid, and uric acid levels at low doses. In contrast, medium to high doses resulted in increased glycogen, decreased ATP, and reduced lactic acid (only at high doses), without affecting uric acid. These findings suggest that Compound 1 may adversely affect muscle function in rats, potentially due to the glycogen inhibition effects of GP inhibitors. This study provides crucial safety data and insights into the long-term effects of GP inhibitors on rat muscles, which will guide future developments and applications.

Enhancing performance: unveiling the physiological impact of submaximal and supramaximal tests on mixed martial arts athletes in the -61 kg and -66 kg weight divisions

This study delves into the intricate details of Mixed Martial Arts (MMA) by examining key variables such as maximal oxygen uptake (VO2 peak), aerobic energy (EAER), anaerobic energy (EAN), and accumulated O2 deficit (DOA). By investigating associations and comparing athletes in the -61 kg bantamweight and -66 kg featherweight weight divisions, we aim to shed light on their physiological characteristics. The sample consisted of 20 male volunteers separated into two paired groups: ten athletes in the category up to 61 kg (age: 27.7 ± 5.9 years old, height: 170.9 ± 3.4 cm, body mass: 72.8 ± 1.4 kg, fat percentage: 9.5% ± 3.0%, professional experience: 7.5 ± 7.1 years) and ten athletes up to 66 kg (age: 27.6 ± 2.9 years old, height: 176.0 ± 5.5 cm, body mass: 77.0 ± 1.5 kg, fat percentage: 7.85% ± 0.3%, professional experience: 5.5 ± 1.5 years). Remarkably, our findings revealed striking similarities between the two weight divisions. Furthermore, we discovered a negative correlation between VO2 peak and the number of MMA fights, indicating a potential impact of professional experience on aerobic capacity (r = -0.65, p < 0.01). Additionally, the number of fights exhibited negative correlations with anaerobic energy (r = -0.53, p < 0.05) and total energy cost (r = -0.54, p < 0.05). These results provide valuable insights for designing training programs in the context of MMA. While training both weight divisions together can be beneficial, it is equally crucial to incorporate specific weight-class-focused training to address each division's unique physical demands and requirements.